Federal contract award

75FCMC25F0005

SERVICES RELATED TO OVERSIGHT ACTIVITIES OF MEDICARE ADVANTAGE, PRESCRIPTION DRUG PLAN, PROGRAMS OF ALL-INCLUSIVE CARE FOR THE ELDERLY, AND OTHER RELATED HEALTH CARE ORGANIZATIONS

Research the contractorView USAspending sourceSave to my pursuit research

Award details

Obligations, current value and potential value describe different measures; they are never added together.

FieldReported value
AgencyDepartment of Health and Human Services
OfficeOFC OF ACQUISITION AND GRANTS MGMT
NAICS541211 — Offices of Certified Public Accountants
PSCR704 — Auditing Services
Parent award / vehicleGS23F056AA
Set-asideNot reported
Pricing typeTIME AND MATERIALS
Obligations$7.8M
Current contract value$7.8M
Potential contract value / ceiling$26.9M
Start dateDec 30, 2024
Current end dateDec 31, 2026
Potential end dateSep 29, 2028
Latest award activityApr 27, 2026
Source loadedSep 26, 2026

Funding and modification history

Showing the latest 8 of 8 loaded transactions. Negative values are deobligations.

DateModificationObligation changeDescription
Apr 27, 2026P00007$0SERVICES RELATED TO OVERSIGHT ACTIVITIES OF MEDICARE ADVANTAGE, PRESCRIPTION DRUG PLAN, PROGRAMS OF ALL-INCLUSIVE CARE FOR THE ELDERLY, AND OTHER RELATED HEALTH CARE ORGANIZATIONS
Mar 20, 2026P00006$0SERVICES RELATED TO OVERSIGHT ACTIVITIES OF MEDICARE ADVANTAGE, PRESCRIPTION DRUG PLAN, PROGRAMS OF ALL-INCLUSIVE CARE FOR THE ELDERLY, AND OTHER RELATED HEALTH CARE ORGANIZATIONS
Mar 5, 2026P00005$0SERVICES RELATED TO OVERSIGHT ACTIVITIES OF MEDICARE ADVANTAGE, PRESCRIPTION DRUG PLAN, PROGRAMS OF ALL-INCLUSIVE CARE FOR THE ELDERLY, AND OTHER RELATED HEALTH CARE ORGANIZATIONS
Mar 4, 2026P00004$-2.5MEOI::EXECUTIVE ORDER 14222, IMPLEMENTING THE PRESIDENT'S "DEPARTMENT OF GOVERNMENT EFFICIENCY INITIATIVE::EOI BILATERAL MODIFICATION TO DESCOPE
Aug 18, 2025P00003$0SERVICES RELATED TO OVERSIGHT ACTIVITIES OF MEDICARE ADVANTAGE, PRESCRIPTION DRUG PLAN, PROGRAMS OF ALL-INCLUSIVE CARE FOR THE ELDERLY, AND OTHER RELATED HEALTH CARE ORGANIZATIONS
Mar 21, 2025P00002$0SERVICES RELATED TO OVERSIGHT ACTIVITIES OF MEDICARE ADVANTAGE, PRESCRIPTION DRUG PLAN, PROGRAMS OF ALL-INCLUSIVE CARE FOR THE ELDERLY, AND OTHER RELATED HEALTH CARE ORGANIZATIONS
Jan 13, 2025P00001$0SERVICES RELATED TO OVERSIGHT ACTIVITIES OF MEDICARE ADVANTAGE, PRESCRIPTION DRUG PLAN, PROGRAMS OF ALL-INCLUSIVE CARE FOR THE ELDERLY, AND OTHER RELATED HEALTH CARE ORGANIZATIONS
Dec 30, 20240$10.3MSERVICES RELATED TO OVERSIGHT ACTIVITIES OF MEDICARE ADVANTAGE, PRESCRIPTION DRUG PLAN, PROGRAMS OF ALL-INCLUSIVE CARE FOR THE ELDERLY, AND OTHER RELATED HEALTH CARE ORGANIZATIONS

Estimated positioning window

Sep 29, 2027 – Mar 29, 2028

Recompete signal:
65/100

Why this recompete signal

Contract timing and recorded acquisition signals at the time of calculation.

Stored score: 65/100. Available recorded signals: 60 points.

Contract end 2028-09-29 (705 days from calculation)
+25 points
17 historical awards in this buyer and category group
+15 points
8 recorded award transactions
+10 points
Latest award action: 2026-04-27
+5 points
Parent award identifier recorded
+5 points
Solicitation identifier recorded
+0 points
Linked official forecast
+0 points
Calculated on
2026-10-25 10:18:04.631876+00:00

The historical group combines buyer, NAICS, and PSC. Multiple awards in this group do not by themselves establish repeated competitions.

Rule-based research score; it does not measure your chance of winning.

This older calculation does not retain a complete reproducible breakdown. Missing or changed inputs are not assigned invented points: Original award-value bonus input.

USAspending award record

. Rule-based research score; positioning dates are estimates.

Recompete score calculated Oct 25, 2026.

Research next steps

  1. Check the linked forecast or SAM for a confirmed solicitation and current timing.
  2. Verify whether remaining options may extend performance beyond the current end date.
  3. Confirm the ordering vehicle and your eligibility or a qualified teaming route.
  4. Review the award scope and buyer evidence before making a bid/no-bid decision.